Neuland Laboratories
Neuland Laboratories Performance
Day Range
- Low 5,109.00
- High 5,329.90
52 Week Range
- Low 1,318.10
- High 5,601.40
- Open Price5,325.00
- Previous Close5,312.75
- Volume65142
Start SIP in Neuland Laboratories
Start SIPNeuland Laboratories Investment Rating
-
Master Rating:
-
Neuland Laboratories has an operating revenue of Rs. 1,457.07 Cr. on a trailing 12-month basis. An annual revenue growth of 26% is outstanding, Pre-tax margin of 18% is great, ROE of 16% is good. The company has a reasonable debt to equity of 7%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 21% and 70% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 26% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 99 which is a GREAT score indicating consistency in earnings, a RS Rating of 94 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 75 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of A is the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has great fundamentals and technical strength to stay in momentum.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 418 | 363 | 407 | 269 | 294 | 221 | 256 |
Operating Expenses Qtr Cr | 280 | 266 | 287 | 215 | 225 | 193 | 217 |
Operating Profit Qtr Cr | 137 | 97 | 120 | 54 | 69 | 28 | 39 |
Depreciation Qtr Cr | 15 | 14 | 13 | 13 | 13 | 13 | 12 |
Interest Qtr Cr | 4 | 2 | 4 | 3 | 3 | 3 | 3 |
Tax Qtr Cr | 32 | 21 | 26 | 8 | 15 | 3 | 2 |
Net Profit Qtr Cr | 89 | 62 | 85 | 30 | 38 | 10 | 22 |
Neuland Laboratories Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 10
- Bearish Moving Average
- ___
- 6
- 20 Day
- ₹5,066.16
- 50 Day
- ₹4,584.07
- 100 Day
- ₹4,074.98
- 200 Day
- ₹3,401.06
- 20 Day
- ₹5,226.80
- 50 Day
- ₹4,407.78
- 100 Day
- ₹4,015.01
- 200 Day
- ₹3,142.63
Neuland Laboratories Resistance and Support
Resistance | |
---|---|
First Resistance | 5,268.07 |
Second Resistance | 5,409.43 |
Third Resistance | 5,488.97 |
RSI | 56.47 |
MFI | 62.86 |
MACD Single Line | 306.09 |
MACD | 258.15 |
Support | |
---|---|
First Resistance | 5,047.17 |
Second Resistance | 4,967.63 |
Third Resistance | 4,826.27 |
Neuland Laboratories Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 70,152 | 5,469,050 | 77.96 |
Week | 51,555 | 3,714,538 | 72.05 |
1 Month | 70,210 | 3,139,106 | 44.71 |
6 Month | 49,653 | 2,533,307 | 51.02 |
Neuland Laboratories Result Highlights
Neuland Laboratories Synopsis
NSE-Medical-Diversified
Neuland Laborat is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1191.20 Cr. and Equity Capital is Rs. 12.90 Cr. for the Year ended 31/03/2023. Neuland Laboratories Ltd. is a Public Limited Listed company incorporated on 07/01/1984 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85195TG1984PLC004393 and registration number is 004393.Market Cap | 6,578 |
Sales | 1,457 |
Shares in Float | 0.82 |
No of funds | 116 |
Yield | 0.19 |
Book Value | 6.7 |
U/D Vol ratio | 2 |
LTDebt / Equity | 8 |
Alpha | 0.47 |
Beta | 1.22 |
Neuland Laboratories
Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
---|---|---|---|---|
Promoters | 35.97% | 36.03% | 36.14% | 36.14% |
Mutual Funds | 1.94% | 1.57% | 0.99% | 0.79% |
Foreign Portfolio Investors | 21.57% | 20.19% | 18.14% | 17.7% |
Individual Investors | 27.86% | 29.01% | 29.85% | 30.09% |
Others | 12.66% | 13.2% | 14.88% | 15.28% |
Neuland Laboratories Management
Name | Designation |
---|---|
Dr. Davuluri Rama Mohan Rao | Executive Chairman |
Mr. Davuluri Sucheth Rao | Vice Chairman & CEO |
Mr. Davuluri Saharsh Rao | Vice Chairman & Mng.Director |
Dr. Christopher M Cimarusti | Non Executive Director |
Mr. Humayun Dhanrajgir | Ind. Non-Executive Director |
Mrs. Bharati Rao | Ind. Non-Executive Director |
Dr. Nirmala Murthy | Ind. Non-Executive Director |
Mr. Parampally Vasudeva Maiya | Ind. Non-Executive Director |
Mr. Homi Rustum Khusrokhan | Ind. Non-Executive Director |
Mr. Prasad Raghava Menon | Ind. Non-Executive Director |
Neuland Laboratories Forecast
Price Estimates
Neuland Laboratories Corporate Action
Neuland Laboratories FAQs
What is Share Price of Neuland Laboratories ?
Neuland Laboratories share price is ₹5,126 As on 06 December, 2023 | 03:10
What is the Market Cap of Neuland Laboratories ?
The Market Cap of Neuland Laboratories is ₹6577.5 Cr As on 06 December, 2023 | 03:10
What is the P/E ratio of Neuland Laboratories ?
The P/E ratio of Neuland Laboratories is 24.7 As on 06 December, 2023 | 03:10
What is the PB ratio of Neuland Laboratories ?
The PB ratio of Neuland Laboratories is 6.7 As on 06 December, 2023 | 03:10